ONC201 exerts oncogenic effects beyond its mitochondria-disturbing role in neuroblastoma subsets
Journal of Molecular Medicine · 2025
DOI: 10.1007/s00109-025-02541-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Medicine, 2025. Verfasst von Jyun-Hong Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Kaohsiung Chang Gung Memorial Hospital, Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang …. Hauptthemen laut MEDLINE: Neuroblastoma, Mitochondria, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chang Gung Memorial Hospital, Ministry of Health and Welfare, National Science and Technology Council.
Abstract (Originalsprache)
Neuroblastoma (NB) is a formidable challenge in pediatric oncology due to its intricate molecular landscape, necessitating multifaceted therapeutic approaches. ONC201 is an imipridone antibiotic compound with a promising drug candidate leveraging its potent anticancer properties against the mitochondrial proteases ClpP and ClpX. Despite demonstrating early clinical promise, particularly in MYCN -amplified NB, its efficacy in non- MYCN -amplified NB remains a subject worthy of investigation. In this study, we extended the coverage of ONC201 to treat non- MYCN -amplified NB, and our data implicated ONC201’s inability to reduce tumor growth in animal models harboring SK-N-AS or SK-N-FI cell lines. Interestingly, ONC201 induced the expression of oncogenic markers c-Myc and LGR5 while downregulating the tumor suppressor ATRX. While it fails to attenuate tumor neovascularization in non- MYCN -amplified NB xenografts, its effectiveness differs from that of its MYCN-amplified counterpart. Rho zero (ρ0)-SK-N-AS cells treated with ONC201 showed comparable observed trends in parental SK-N-AS cells, including LGR5 upregulation and ATRX downregulation, suggesting that ONC201’s multifaceted actions extend beyond mitochondrial targets. Our elucidation highlights the need to discern molecular signatures when deploying ONC201 monotherapy against NB, which lacks MYCN- amplification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Surgery, Kaohsiung Chang Gung Memorial Hospital, Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Kaohsiung, Taiwan.
- Center for Mitochondrial Research and Medicine, College of Medicine Chang Gung University, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
- Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
- Department of Pathology, Kaohsiung Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Kaohsiung, Taiwan.
- Department of Surgery, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
- Department of Pediatric Surgery, Kaohsiung Chang Gung Memorial Hospital, Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Kaohsiung, Taiwan. jhchuang@cloud.cgmh.org.tw.
Förderung
- Chang Gung Memorial Hospital
- Ministry of Health and Welfare
- National Science and Technology Council
Zitieren
APA
Jiang, J. H., Lin, Y. H., Liao, P. L., Chen, T. Y., Chuang, H. C., Huang, C. C., Hsu, W. M., Chuang, J. H., & Lian, W. S. (2025). ONC201 exerts oncogenic effects beyond its mitochondria-disturbing role in neuroblastoma subsets. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-025-02541-0
Vancouver
Jiang JH, Lin YH, Liao PL, Chen TY, Chuang HC, Huang CC, et al. ONC201 exerts oncogenic effects beyond its mitochondria-disturbing role in neuroblastoma subsets. Journal of Molecular Medicine. 2025. doi:10.1007/s00109-025-02541-0
BibTeX
@article{Jiang2025,
author = {Jiang, Jyun-Hong and Lin, Yu-Han and Liao, Pei-Lin and Chen, Ting-Ya and Chuang, Hui-Ching and Huang, Chao-Cheng and Hsu, Wen-Ming and Chuang, Jiin-Haur and Lian, Wei-Shiung},
title = {ONC201 exerts oncogenic effects beyond its mitochondria-disturbing role in neuroblastoma subsets},
journal = {Journal of Molecular Medicine},
year = {2025},
doi = {10.1007/s00109-025-02541-0}
}
EUVIMED